Donald G. Payan
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Donald G. Payan
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 32 | |
Khepri Pharmaceuticals, Inc.
 Khepri Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Quest Diagnostics, Inc., Khepri Pharmaceuticals, Inc. is a developer of pharmaceutical products. The company is based in South San Francisco, CA. The company was founded by Donald G. Payan. Khepri Pharmaceuticals was acquired by Arris Pharmaceutical Corp. on December 26, 1995 for $33.40 million.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Donald G. Payan tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| PONIARD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
CoTherix, Inc.
 CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| CHEMOCENTRYX, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| HUMANIGEN, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Ceregene, Inc.
 Ceregene, Inc. Pharmaceuticals: MajorHealth Technology Ceregene, Inc. develops pharmaceutical products for neurodegenerative disorders. The company was founded in January 2001 and it is headquartered in Richmond, CA. | Pharmaceuticals: Major | Founder Director/Board Member | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Nodality, Inc.
 Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | Biotechnology | Founder Founder | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree | |
| AFFYMAX, INC. | Biotechnology | Director of Finance/CFO Chairman Chief Tech/Sci/R&D Officer | |
| Iowa State University | College/University | Undergraduate Degree | |
Twilight Venture Partners LLC
 Twilight Venture Partners LLC Investment ManagersFinance Twilight Venture Partners LLC (Twilight Venture Partners) is a venture capital firm founded in 2002 by Jim R. Baumgardt, Harry L. Gonso, and Ronald D. Henriksen. The firm is headquartered in Indianapolis, Indiana. | Investment Managers | Founder | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal | |
| Washington State University | College/University | Masters Business Admin | |
Rinat Neuroscience Corp.
 Rinat Neuroscience Corp. BiotechnologyHealth Technology Rinat Neuroscience Corp. manufactures and markets drugs for treating neurological diseases. The company was founded by Arnon Rosenthal and Patrick G. Lynn on November 21, 2000 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| PLUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| PDL BIOPHARMA, INC. | Biotechnology | Director/Board Member Chairman | |
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures LLC (Clarus Ventures) is a venture capital subsidiary of Blackstone, Inc. founded in 2005 by Nicholas G. Galakatos. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Founder | |
| United States Navy (District of Columbia) | Sovereign | Corporate Officer/Principal | |
| Collabra Pharma, Inc. | Founder Founder | ||
IU Ventures
 IU Ventures Investment ManagersFinance IU Ventures (IU ventures) is a venture capital subsidiary of Indiana University founded in 1997. The firm is headquartered in Bloomington, Indiana. | Investment Managers | President | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
| CALITHERA BIOSCIENCES, INC. | Biotechnology | Founder Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Chief Executive Officer Founder | |
| THERAVANCE BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Stanford University School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| AKOYA BIOSCIENCES, INC. | Biotechnology | Founder Director/Board Member | |
| ELEDON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 51 |
Settori
| Health Technology | 36 |
| Consumer Services | 8 |
| Finance | 5 |
| Retail Trade | 2 |
| Commercial Services | 2 |
Posizioni
| Director/Board Member | 212 |
| Corporate Officer/Principal | 72 |
| Independent Dir/Board Member | 56 |
| Founder | 36 |
| Chairman | 34 |
Contatti più connessi
| Insiders | |
|---|---|
| Nicholas Simon | 33 |
| Alan Frazier | 31 |
| Walter Moos | 30 |
| Stephen Sherwin | 26 |
| Dennis J. Henner | 26 |
| Jean Deleage | 23 |
| Gary Lyons | 20 |
| Thomas Raffin | 19 |
| Peter S. Ringrose | 19 |
| Hollings Renton | 17 |
| Ron D. Henriksen | 17 |
| Susan Molineaux | 17 |
| Keith Katkin | 16 |
| Bradford Goodwin | 15 |
| Garry Nolan | 13 |
- Borsa valori
- Insiders
- Donald G. Payan
- Connessioni Società
